Surveillance Strategies After Definitive Therapy of Invasive Bladder Cancer

Overview

Journal Can Urol Assoc J

Specialty Urology

Date 2009 Dec 19

PMID 20019993

Citations 15

Authors

Ilias Cagiannos

Christopher Morash

Affiliations

Soon will be listed here.

Abstract

Following definitive therapy for muscle invasive bladder cancer, patients remain at risk for local and distant recurrence. Additionally, recurrences can result from formation of new tumours elsewhere in the urinary tract. We review patterns of recurrence and the prognosis associated with recurrence. Optimal surveillance strategies are discussed.

Citing Articles

Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma.

Bhalla S, Passarelli R, Biswas A, De S, Ghodoussipour S J Clin Med. 2024; 13(7).

PMID: 38610824 PMC: 11012937. DOI: 10.3390/jcm13072057.

Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies.

Kim K, Lee H, Ha H, Seo H Investig Clin Urol. 2023; 64(3):202-218.

PMID: 37341001 PMC: 10172053. DOI: 10.4111/icu.20230006.

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study.

Roupret M, Brouquet A, Colrat F, Diez-Andreu P, Prudent A, Chartier M World J Urol. 2023; 41(4):1069-1075.

PMID: 36929410 PMC: 10018592. DOI: 10.1007/s00345-023-04335-w.

Imaging Tips and Tricks in Management of Renal and Urothelial Malignancies.

Sanyal S, Arora A, Nisreen A, Mohamed K, Mohammad S, Baruah D Indian J Radiol Imaging. 2022; 32(2):213-223.

PMID: 35924135 PMC: 9340167. DOI: 10.1055/s-0042-1744520.

Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence.

Zattoni F, Bednarova I, Morlacco A, Motterle G, Beltrami P, Dal Moro F Cent European J Urol. 2021; 73(4):445-456.

PMID: 33552570 PMC: 7848846. DOI: 10.5173/ceju.2020.0168.R1.

References

Lin D, Herr H, Dalbagni G . Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol. 2003; 169(3):961-3. DOI: 10.1097/01.ju.0000051907.16079.63. View

Eapen L, Stewart D, Collins J, Peterson R . Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer. J Urol. 2004; 172(4 Pt 1):1276-80. DOI: 10.1097/01.ju.0000140456.42509.b6. View

Shipley W, Kaufman D, Zehr E, Heney N, Lane S, Thakral H . Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology. 2002; 60(1):62-7; discussion 67-8. DOI: 10.1016/s0090-4295(02)01650-3. View

Baron J, Gibod L, Steg A . Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma. Eur Urol. 1989; 16(4):283-5. DOI: 10.1159/000471592. View

Balaji K, McGuire M, Grotas J, Grimaldi G, Russo P . Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation. J Urol. 1999; 162(5):1603-6. DOI: 10.1016/s0022-5347(05)68176-1. View

Pisters L, Westney L . The management of locally recurrent invasive bladder cancer following radical cystectomy. Semin Urol Oncol. 1996; 14(2):112-9. View

Lebret T, Herve J, Barre P, Gaudez F, Lugagne P, Barbagelatta M . Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy. Eur Urol. 1998; 33(2):170-4. DOI: 10.1159/000019550. View

Tran W, Serio A, Raj G, Dalbagni G, Vickers A, Bochner B . Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. J Urol. 2007; 179(1):96-100. DOI: 10.1016/j.juro.2007.08.131. View

Freeman J, Esrig D, Stein J, SKINNER D . Management of the patient with bladder cancer. Urethral recurrence. Urol Clin North Am. 1994; 21(4):645-51. View

10.

Saxman S, Propert K, Einhorn L, Crawford E, Tannock I, Raghavan D . Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol. 1997; 15(7):2564-9. DOI: 10.1200/JCO.1997.15.7.2564. View

11.

Jemal A, Murray T, Ward E, Samuels A, Tiwari R, Ghafoor A . Cancer statistics, 2005. CA Cancer J Clin. 2005; 55(1):10-30. DOI: 10.3322/canjclin.55.1.10. View

12.

POOLE-WILSON D, Barnard R . Total cystectomy for bladder tumours. Br J Urol. 1971; 43(1):16-24. DOI: 10.1111/j.1464-410x.1971.tb04926.x. View

13.

Volkmer B, Kuefer R, Bartsch Jr G, Gust K, Hautmann R . Oncological followup after radical cystectomy for bladder cancer-is there any benefit?. J Urol. 2009; 181(4):1587-93. DOI: 10.1016/j.juro.2008.11.112. View

14.

Stein J, Esrig D, Freeman J, Grossfeld G, Ginsberg D, Cote R . Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women. Urology. 1998; 51(6):951-5. DOI: 10.1016/s0090-4295(98)00099-5. View

15.

SKINNER D, Lieskovsky G . Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol. 1984; 131(6):1069-72. DOI: 10.1016/s0022-5347(17)50809-5. View

16.

Herr H . Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy. Urology. 1985; 25(2):127-34. DOI: 10.1016/0090-4295(85)90527-8. View

17.

Roehrborn C, Sagalowsky A, Peters P . Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder. J Urol. 1991; 146(1):36-9. DOI: 10.1016/s0022-5347(17)37708-x. View

18.

Schoenberg M, Walsh P, Breazeale D, Marshall F, Mostwin J, Brendler C . Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol. 1996; 155(2):490-4. View

19.

Dalbagni G, Genega E, Hashibe M, Zhang Z, Russo P, Herr H . Cystectomy for bladder cancer: a contemporary series. J Urol. 2001; 165(4):1111-6. View

20.

Stein J, Lieskovsky G, Cote R, Groshen S, Feng A, Boyd S . Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19(3):666-75. DOI: 10.1200/JCO.2001.19.3.666. View